CHF138.50 Cicor (CICN.SW) on SIX 12 Feb 2026: AI stocks insight

CICN.SW stock opens the pre-market at CHF138.50, down CHF9.00 (-6.10%), after a recent swing from its 12‑month high of CHF229.00. We focus on Cicor Technologies Ltd. (CICN.SW) listed on SIX in Switzerland and link the move to valuation, cash flow metrics and near-term catalysts. This piece gives a concise AI stocks angle: fundamentals, technicals, Meyka AI grading, and a model-led 12‑month price outlook for investors monitoring technology hardware exposure.

CICN.SW stock: pre-market snapshot and price action

Cicor Technologies Ltd. (CICN.SW) is trading at CHF138.50 with a day low at CHF132.50 and a day high at CHF139.00. Volume stands at 17,314.00 vs average 20,476.00, implying light but above-average interest. The one‑day move of -6.10% follows a recent 1‑month gain of 13.33% and a 3‑month decline of -21.47%, signalling short-term rotation rather than a new trend.

CICN.SW stock: fundamentals and valuation

Cicor reports EPS CHF5.30 and market PE 27.26 based on the latest quote. Market capitalisation is CHF630,492,949.00 and shares outstanding are 4,363,273.00. Key ratios: price to book 4.35, price to sales 2.34, and free cash flow yield 4.50%. Revenue and operating cash flow grew year‑on‑year, while net debt to EBITDA sits near 2.88, highlighting leverage sensitivity in slower demand cycles.

CICN.SW stock: technical picture for AI-focused traders

Technical indicators show a constructive but cautious setup. RSI is 37.11, below neutral and MACD histogram is slightly positive, signalling short‑term consolidation. The 50‑day average is CHF133.65 and the 200‑day average is CHF161.19, placing price below the long‑term mean. Bollinger middle band at CHF133.75 suggests current price is near the band midline but well under the upper band at CHF174.74.

CICN.SW stock: catalysts, earnings and sector context

Upcoming catalysts include the scheduled earnings announcement on 2026-03-11 and ongoing demand from medical and aerospace end markets. Cicor’s Technology sector peers have a higher average PE near 29.17, which frames Cicor’s valuation. Positive revenue growth in FY2024 of 23.33% supports the outlook, but extended inventory cycles remain a sector headwind.

CICN.SW stock: Meyka AI grade and model forecast

Meyka AI rates CICN.SW with a score out of 100: 76.58 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 and sector comparison, financial growth, key metrics, forecasts, and analyst inputs. Meyka AI’s forecast model projects a 12‑month target of CHF217.08, implying an upside of 56.75% from the current CHF138.50. Forecasts are model‑based projections and not guarantees.

CICN.SW stock: risks, trading ideas and position sizing

Primary risks are inventory buildup and interest sensitivity given interest coverage near 1.05. A conservative approach: scale in at CHF130.00–CHF140.00 with stops below CHF120.00 and a medium target zone CHF160.00–CHF217.08. For AI stocks exposure, treat Cicor as selective hardware play rather than broad AI software exposure and size positions to limit portfolio volatility.

Final Thoughts

Key takeaways for CICN.SW stock: the pre‑market price of CHF138.50 reflects short‑term profit taking inside a longer recovery from the 12‑month low of CHF65.40. Fundamentals show solid cash flow per share CHF6.30 and EPS CHF5.30, but elevated leverage and a high price/book of 4.35 raise valuation questions. Meyka AI’s forecast model projects a 12‑month level of CHF217.08, an implied upside of 56.75% versus the current price; this is our model baseline, not a guarantee. Catalysts that could validate the forecast include stronger order intake in medical and aerospace, and an earnings beat on 2026-03-11. On the downside, slower industrial demand or working capital pressure could push price toward the mid‑range support near CHF105.00. We link the company website and our Meyka stock page for primary documents and live data: Cicor website and CICN.SW on Meyka. Meyka AI provides this as an AI‑powered market analysis platform view; investors should combine it with their own research and risk limits.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.